- Home
- SKYE vs FUSB Comparison
SKYE vs FUSB Comparison
Compare SKYE & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- FUSB
- Stock Information
- Founded
- SKYE 2012
- FUSB 1952
- Country
- SKYE United States
- FUSB United States
- Employees
- SKYE N/A
- FUSB N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- FUSB Major Banks
- Sector
- SKYE Health Care
- FUSB Finance
- Exchange
- SKYE Nasdaq
- FUSB Nasdaq
- Market Cap
- SKYE 80.7M
- FUSB 73.3M
- IPO Year
- SKYE N/A
- FUSB N/A
- Fundamental
- Price
- SKYE $2.95
- FUSB $12.47
- Analyst Decision
- SKYE Buy
- FUSB
- Analyst Count
- SKYE 6
- FUSB 0
- Target Price
- SKYE $18.67
- FUSB N/A
- AVG Volume (30 Days)
- SKYE 169.1K
- FUSB 1.8K
- Earning Date
- SKYE 02-13-2025
- FUSB 01-27-2025
- Dividend Yield
- SKYE N/A
- FUSB 2.27%
- EPS Growth
- SKYE N/A
- FUSB 0.00
- EPS
- SKYE N/A
- FUSB 1.33
- Revenue
- SKYE N/A
- FUSB $39,110,000.00
- Revenue This Year
- SKYE N/A
- FUSB N/A
- Revenue Next Year
- SKYE N/A
- FUSB N/A
- P/E Ratio
- SKYE N/A
- FUSB $9.29
- Revenue Growth
- SKYE N/A
- FUSB N/A
- 52 Week Low
- SKYE $2.31
- FUSB $8.66
- 52 Week High
- SKYE $19.41
- FUSB $14.30
- Technical
- Relative Strength Index (RSI)
- SKYE 47.80
- FUSB 46.63
- Support Level
- SKYE $2.53
- FUSB $12.26
- Resistance Level
- SKYE $4.25
- FUSB $12.80
- Average True Range (ATR)
- SKYE 0.43
- FUSB 0.32
- MACD
- SKYE 0.10
- FUSB -0.02
- Stochastic Oscillator
- SKYE 28.84
- FUSB 17.98
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.